Mask Investments Limited (NSE:MASKINVEST)
India · Delayed Price · Currency is INR 141.50
+4.63 (3.38%)
Nov 11, 2026, 2:28 PM IST
Mask Investments Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.12 | 3.53 | 0.94 | 0.46 | 0.25 | 0.62 |
Cash & Short-Term Investments | 0.12 | 3.53 | 0.94 | 0.46 | 0.25 | 0.62 |
Cash Growth | 100.00% | 273.41% | 107.02% | 82.12% | -59.84% | 112.23% |
Receivables | 10.88 | 10.9 | 13.99 | 14.27 | 14.42 | 13.77 |
Other Current Assets | - | 0.1 | 0.41 | 0.74 | 0.33 | 0.3 |
Total Current Assets | 11 | 14.52 | 15.34 | 15.47 | 15.01 | 14.7 |
Long-Term Investments | 625.89 | 602.79 | 974.65 | 1,539 | 975.48 | 716.76 |
Other Long-Term Assets | - | - | - | -0 | 0 | - |
Total Assets | 636.88 | 617.31 | 989.99 | 1,555 | 990.48 | 731.46 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.08 | 0.6 | 2.43 | 1.55 | 1.73 | 0.92 |
Accrued Expenses | - | - | 0 | 0.08 | 0.08 | 0.01 |
Short-Term Debt | 4.49 | 7.25 | 6.95 | 8.28 | 7.72 | 8.85 |
Current Income Taxes Payable | 0.15 | 0.25 | 0.13 | 0.07 | 0.2 | 0.22 |
Other Current Liabilities | 0 | - | - | - | 0 | - |
Total Current Liabilities | 4.72 | 8.11 | 9.51 | 9.99 | 9.73 | 10.01 |
Other Long-Term Liabilities | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Total Liabilities | 4.75 | 8.14 | 9.54 | 10.02 | 9.76 | 10.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 30.52 | 30.52 | 30.52 | 30.52 | 30.52 | 30.52 |
Retained Earnings | - | 11.92 | 11.33 | 10.99 | 10.77 | 10.18 |
Comprehensive Income & Other | 601.62 | 566.74 | 938.6 | 1,503 | 939.43 | 680.72 |
Shareholders' Equity | 632.13 | 609.18 | 980.45 | 1,545 | 980.72 | 721.42 |
Total Liabilities & Equity | 636.88 | 617.31 | 989.99 | 1,555 | 990.48 | 731.46 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 4.49 | 7.25 | 6.95 | 8.28 | 7.72 | 8.85 |
Net Cash (Debt) | -4.37 | -3.73 | -6.01 | -7.83 | -7.47 | -8.23 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.49 | -1.22 | -1.97 | -2.57 | -2.45 | -2.70 |
Filing Date Shares Outstanding | 3.47 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 |
Total Common Shares Outstanding | 3.47 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 |
Working Capital | 6.28 | 6.42 | 5.83 | 5.49 | 5.27 | 4.69 |
Book Value Per Share | 182.35 | 199.63 | 321.30 | 506.19 | 321.39 | 236.41 |
Tangible Book Value | 632.13 | 609.18 | 980.45 | 1,545 | 980.72 | 721.42 |
Tangible Book Value Per Share | 182.35 | 199.63 | 321.30 | 506.19 | 321.39 | 236.41 |